Double-blind, Vehicle-controlled, Randomised, Multi-centre Study to Evaluate the Efficacy and Safety of LH-8 Cutaneous Solution in Children and Adolescents With Moderate to Severe Scalp Alopecia Areata.
Phase of Trial: Phase II/III
Latest Information Update: 21 Sep 2018
At a glance
- Drugs LH 8 (Primary)
- Indications Alopecia areata
- Focus Registrational; Therapeutic Use
- Sponsors Legacy Healthcare
- 07 Mar 2018 Status changed from not yet recruiting to recruiting.
- 14 Aug 2017 New trial record